Novel Strategies for Oxidative Stress Management: Dietary Interventions for Liver and Gut Health

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 3241

Special Issue Editors


E-Mail Website
Guest Editor
Bionutest Research Group—Nutrition and Food Science Area, Faculty of Pharmacy and Food Sciences, University of Valencia, Av. Vicente Andrés Estellés s/n, 46100 Burjassot, Valencia, Spain
Interests: functional foods; bioactive compounds; antioxidant capacity; sterols; phytochemicals; bioaccessibility; bioavailability; bioactivity; cell cultures; chemoprevention; oxidative stress; eryptosis; food by-products
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor Assistant
Nutrition Department, Faculty of Health Sciences, Fernando Pessoa Canarias University, Calle la Juventud s/n, 35450 Las Palmas, Spain
Interests: bioactive compounds; nutraceuticals; intestinal health; in vitro models; molecular biology; bioavailability; simulated gastrointestinal digestion; antioxidant; anti-inflammatory

Special Issue Information

Dear Colleagues,

Oxidative stress is a critical driver in the pathogenesis and progression of liver and gastrointestinal diseases, including nonalcoholic fatty liver disease, hepatocellular carcinoma, and inflammatory bowel diseases. Growing evidence highlights the potential of dietary interventions to modulate oxidative stress pathways, restore redox homeostasis, and slow or prevent disease progression. Bioactive dietary compounds with antioxidant properties act on multiple biological levels, influencing inflammatory signaling, mitochondrial function, endogenous antioxidant systems, and gut–liver axis communication.

This Special Issue aims to showcase innovative research on dietary strategies to mitigate oxidative stress and improve liver and gut health. We welcome original research articles and comprehensive reviews that investigate the molecular mechanisms by which dietary components attenuate oxidative damage. Topics of interest include the regulation of antioxidant defense networks, activation of redox-sensitive transcription factors, modulation of inflammatory pathways, and role of gut microbiota in maintaining redox balance across hepatic and intestinal systems.

Submissions may include preclinical models (cellular and animal) and human intervention studies. By bringing together mechanistic insights and translational findings, this Special Issue seeks to support the development of evidence-based dietary recommendations for the prevention and management of oxidative stress-related liver and gastrointestinal disorders.

Dr. Antonio Cilla
Guest Editor

Dr. Mussa Makran
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antioxidant compounds
  • phytochemicals
  • dietary interventions
  • hepatic disease
  • intestinal disease
  • redox homeostasis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 4394 KB  
Review
Bilirubin Hepatic and Intestinal Transport and Catabolism: Physiology, Pathophysiology, and Benefits
by Zachary A. Kipp, Sally N. Pauss, Genesee J. Martinez, Terry D. Hinds, Jr. and Wang-Hsin Lee
Antioxidants 2025, 14(11), 1326; https://doi.org/10.3390/antiox14111326 - 3 Nov 2025
Viewed by 2956
Abstract
Bilirubin, a metabolite derived from heme degradation, has traditionally been regarded as a waste product and a marker of liver injury. However, increasing evidence suggests that bilirubin also functions as a hormone, and reduced levels are associated with metabolic dysfunction. Studies have shown [...] Read more.
Bilirubin, a metabolite derived from heme degradation, has traditionally been regarded as a waste product and a marker of liver injury. However, increasing evidence suggests that bilirubin also functions as a hormone, and reduced levels are associated with metabolic dysfunction. Studies have shown a strong association between low circulating bilirubin levels and an increased risk of metabolic disorders and cardiovascular disease. To advance bilirubin-based treatment strategies, it is essential to elucidate the mechanisms underlying bilirubin transport and metabolism. Therefore, we provide an in-depth discussion of bilirubin production and its subsequent fates, with a particular focus on the transport between the liver and the intestine. We describe the molecular players involved in heme degradation and biliverdin formation, leading to bilirubin production, followed by its transport from the bloodstream to hepatocytes and from the liver to the intestine. We discuss intestinal bilirubin catabolism, including the microbiome generation of urobilinogen, urobilin, and other metabolites. Finally, we discuss how bilirubin clearance and catabolism intersect with its metabolic effects, highlighting potential therapeutic targets. By integrating these aspects, this review provides a comprehensive understanding of bilirubin’s physiological importance, intestinal transport, and breakdown, as well as insights into novel strategies for treating hypobilirubinemia-associated disorders. Full article
Show Figures

Figure 1

Back to TopTop